Interact to see
Advertisement
Advertisement
MEDGX vs REBAX
MEDGX vs REBAX Comparison
Open Charts MEDGX vs REBAX
MFS Emerging Markets Debt R4
Price$12.65
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets7.63B
Columbia Emerging Markets Bond A
Price$10.10
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets347.19M
MEDGX vs REBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
MEDGX vs. REBAX commentary
Nov 20, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDGX is a Hold and REBAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDGX has more cash in the bank: 7.63B vs. REBAX (347M). MEDGX pays higher dividends than REBAX: MEDGX (5.33) vs REBAX (4.77). MEDGX was incepted earlier than REBAX: MEDGX (17 years) vs REBAX (20 years). REBAX (1.13) is less costly to investors than MEDGX (0.82). MEDGX has a lower initial minimum investment than REBAX: MEDGX (0) vs REBAX (2000). REBAX (11.05) and MEDGX (10.80) have marching annual gain over last year. MEDGX return over 5 years is better than : 11.84 vs. REBAX (8.73).
| MEDGX | REBAX | MEDGX / REBAX | |
| Total Expense Ratio | 0.81 | 1.13 | 72% |
| Annual Report Gross Expense Ratio | 0.82 | 1.13 | 73% |
| Fund Existence | 17 years | 20 years | - |
| Gain YTD | 10.570 | 11.258 | 94% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.63B | 347M | 2,198% |
| Annual Yield % from dividends | 5.33 | 4.77 | 112% |
| Returns for 1 year | 10.80 | 11.05 | 98% |
| Returns for 3 years | 35.71 | 33.81 | 106% |
| Returns for 5 years | 11.84 | 8.73 | 136% |
| Returns for 10 years | 50.53 | 43.85 | 115% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers